Veterinary studies on Omega-3 and dog arthritis

Is your dog stiff when getting up in the morning, lagging behind on walks, or limping after just a few minutes of exercise? These signs are often caused by joint inflammation. This biological process is far more complex than simple "wear and tear", and it plays a central role in how canine osteoarthritis develops.

For years, veterinarians have been studying Omega-3 fatty acids, known for their anti-inflammatory benefits. But how do these nutrients actually work in the joints? And what does the science show in dogs?

Joint inflammation: how it works

Joint inflammation starts when cartilage and nearby tissues begin to break down. That triggers a chain reaction:

Pro-inflammatory enzymes kick in: COX and LOX

These enzymes are cyclooxygenases (COX) and lipoxygenases (LOX). They convert fatty acids in cell membranes into small molecules that drive inflammation, including prostaglandins and leukotrienes, the culprits behind pain, heat, and swelling in the joint.

Cytokines are released: TNF-α, IL-1β, IL-6

Cytokines are chemical messengers made by immune cells. TNF-α (tumour necrosis factor alpha), IL-1β (interleukin 1 beta) and IL-6 are among the most aggressive: they fuel inflammation, keep pain going and increase the activity of destructive enzymes. Think of them as biological amplifiers that intensify the inflammatory signal.

Osteoclasts become overactive

Osteoclasts are specialised cells that break down bone. When they're too active, they increase the breakdown of subchondral bone, the layer just beneath the cartilage. The joint loses stability, becomes more fragile and osteoarthritis progresses faster.

Omega-3 for dogs: how they ease joint inflammation

Joint inflammation can feel like an endless cycle, but certain nutrients can intervene at several points in this biological cascade. Omega-3 fatty acids, especially EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), play a central role in keeping these mechanisms in check.

What are omega-3 fatty acids?

Omega-3s are essential polyunsaturated fatty acids. They're called essential because dogs can't make them on their own. They have to come from food. They are polyunsaturated because their chemical structure has multiple double bonds, giving them distinctive benefits for cell membranes and the regulation of inflammation.

Three omega-3s are especially well known:

• ALA (alpha-linolenic acid): found in plant oils such as flaxseed, rapeseed and chia. In dogs, ALA must be converted into EPA and DHA before it can support joint health. However, conversion is very limited, often below 5%, so most ALA is not converted into these active forms.
• EPA (eicosapentaenoic acid): found in fish, shellfish, and algae. One of the key anti-inflammatory players.
• DHA (docosahexaenoic acid): also from marine sources; it helps regulate immune cells and protect tissues.

1. How omega-3 affects COX and LOX enzymes: COX and LOX enzymes normally use arachidonic acid, an omega-6 fatty acid involved in producing pro-inflammatory mediators. When enough EPA is available, it competes with arachidonic acid and favours the production of less pro-inflammatory mediators, helping to ease pain and swelling.
2. Taming pro-inflammatory cytokines: DHA also influences cytokines linked to inflammation, including TNF-α, IL-1β and IL-6. By reducing the production of these messengers, it helps prevent the inflammatory response from escalating.
3. Building "pro-resolving" molecules: EPA and DHA do not simply block inflammation. They are also precursors to resolvins and protectins. These molecules help switch inflammation off and restore balance, or homeostasis, rather than allowing it to persist.
4. Protecting cartilage and regulating bone: DHA also helps protect joint cartilage. In research models, it lowers MMP-13, an enzyme that breaks down the cartilage matrix, and reduces joint damage. Omega-3s also help regulate osteoclasts, the cells that resorb bone.

Bottom line: osteoarthritis keeps enzymes, cytokines, and osteoclasts working against the joints. Omega-3s step in at multiple points to slow that process and help the body keep inflammation in check.

What veterinary research says about omega-3 and dog joints

A growing body of veterinary research has looked at omega-3 EPA and DHA in dogs with osteoarthritis. Studies point to meaningful benefits for joint pain, mobility, and overall comfort on the move.

Clear gains in mobility

Several veterinary trials published in 2010 tested omega-3 EPA and DHA in dogs with osteoarthritis.

One study, published in the Journal of the American Veterinary Medical Association, followed 38 arthritic dogs for 90 days. Researchers found:

• a significant improvement in weight-bearing on the affected leg,
• less lameness,
• and better mobility overall.

Dogs given omega-3 supplements gained an average 5.6% in weight-bearing on the arthritic limb, versus just 0.4% in the control group. Locomotion improved in 82% of supplemented dogs, compared with 38% of controls.

A second trial involving 127 arthritic dogs over 6 months reported:

• greater ease in getting up after rest,
• better walking gait,
• more interest in play,
• and steadily improving joint comfort.

Owners noticed changes after six weeks of supplementation, with stronger results between 12 and 24 weeks.

Blood work supported these findings: EPA and DHA levels rose sharply, while levels of arachidonic acid, a marker associated with joint inflammation, fell.

A third study, published in the Journal of Veterinary Internal Medicine, tested different omega-3 doses in 177 dogs with chronic osteoarthritis.

Dogs on the highest EPA and DHA doses showed:

• a bigger drop in lameness,
• stronger weight-bearing,
• greater joint comfort,
• and owners felt osteoarthritis was progressing more slowly.

The authors suggest that diets rich in omega-3 EPA and DHA may help improve mobility, joint comfort, and key clinical signs of osteoarthritis in dogs.

May help cut back on anti-inflammatory medication

A 2010 study in the Journal of the American Veterinary Medical Association looked at fish-oil omega-3 in 131 dogs with chronic osteoarthritis already receiving carprofen, a widely used veterinary NSAID for joint pain.

The trial ran across 33 US veterinary clinics for 12 weeks. Dogs ate either a standard low-omega-3 diet or one enriched with omega-3. Vets then tapered carprofen based on each dog's clinical response.

Researchers found:

• dogs receiving omega-3 had their carprofen dose reduced sooner,
• anti-inflammatory medication could be reduced more often as symptoms improved,
• and osteoarthritis signs stayed more stable over the follow-up period.

By the end of the study:

• 46% of omega-3 dogs were able to cut their carprofen dose,
• versus 33% in the control group.

The authors also highlight that lowering anti-inflammatory doses may reduce side effects from long-term NSAID use in arthritic dogs.

Researchers conclude that omega-3 fatty acids may offer a valuable nutritional strategy alongside conventional veterinary care for dogs with chronic osteoarthritis.

Less pain and better movement

Two clinical trials tested daily omega-3 EPA and DHA supplementation in dogs with osteoarthritis.

One trial, published in 2016 in Prostaglandins, Leukotrienes and Essential Fatty Acids, followed 78 arthritic dogs for 84 days. Dogs received either a placebo oil or marine omega-3 providing an average of 69 mg/kg/day of EPA and DHA.

Researchers found:

• a significant drop in pain and lameness,
• better comfort during movement,
• higher joint scores,
• and lower blood inflammatory markers.

After 84 days, supplemented dogs improved significantly across all clinical measures of pain, lameness and joint severity. Anti-inflammatory effects appeared by day 42, while improvements in locomotion were especially clear by day 84.

A more recent study, published in 2024 in Animals, tested daily marine omega-3 in 29 adult dogs over 16 weeks at roughly 70 mg/kg/day of EPA and DHA.

Researchers found:

• a sharp rise in blood omega-3 levels,
• pain scores down 16% on average,
• better quality of life,
• and excellent tolerability.

Small dogs showed the greatest changes, with a 38% drop in pain scores and a meaningful boost in quality of life.

The authors suggest daily EPA and DHA supplementation may help ease pain, improve joint comfort, and support quality of life in dogs with osteoarthritis or chronic pain.

Omega-3: the best-evidenced supplement for canine osteoarthritis

A 2022 meta-analysis in the International Journal of Molecular Sciences reviewed every available veterinary study on nutraceuticals for osteoarthritis in dogs and cats. The team analysed 57 papers covering 72 clinical trials on supplements aimed at easing joint pain and improving mobility.

The authors compared the leading nutraceuticals, including omega-3, collagen, glucosamine-chondroitin and other veterinary supplements.

Key findings:

• Omega-3 showed especially strong results for osteoarthritis pain,
• mobility and joint comfort improved across multiple studies,
• collagen had more modest effects,
• and glucosamine-chondroitin supplements showed little meaningful benefit.

The authors also point out that omega-3 trials are among the most numerous and methodologically sound of any nutraceutical reviewed.

Omega-3 supplements have the strongest evidence of efficacy for dogs with osteoarthritis.

Barbeau-Grégoire, 2022

Researchers believe omega-3 EPA and DHA work partly by modulating inflammatory pathways that drive pain and joint breakdown.

The conclusion: among nutritional approaches studied for dogs with osteoarthritis, omega-3 currently has the strongest scientific backing.

Current research suggests omega-3 EPA and DHA may help dogs with osteoarthritis move more easily, feel less joint pain, and stay more comfortable. Today, omega-3 is one of the most thoroughly studied nutritional options for canine joint health.

Where to get omega-3 for your dog

The benefits are well documented, but choosing the right source matters. Dogs can't make enough EPA and DHA on their own; they need to get them from food.

• Plant-based sources (flaxseed, rapeseed and walnut oil): these supply ALA (alpha-linolenic acid), which the body must convert into EPA and DHA. In dogs, that conversion is highly limited, so plant sources offer little direct benefit as sources of EPA and DHA.
• Marine sources: oily fish oils (salmon, sardine and anchovy), krill and microalgae oil deliver EPA and DHA in a directly bioavailable form.
• Premium choice: New Zealand green-lipped mussel oil. Beyond EPA and DHA, it offers rare Omega-3s like ETA and OTA with added anti-inflammatory benefits.

Put simply, not all Omega-3 sources are created equal. Plant oils fall short for dogs, while concentrated marine extracts deliver the strongest results.

Green lipped mussel oil: a natural concentrate of distinctive Omega-3s

The New Zealand green-lipped mussel (Perna canaliculus), eaten for centuries by the Māori, is now one of the most extensively studied Omega-3 sources for joint health. Its oil is extracted using gentle methods such as supercritical CO₂ extraction, which protect its delicate fatty acids.

Why is it classed as a premium source?

• An outstanding fatty acid profile: alongside EPA and DHA, it delivers rare Omega-3s such as ETA and OTA.

  • ETA (eicosatetraenoic acid) works as a selective lipoxygenase (LOX) inhibitor, limiting the production of pro-inflammatory leukotrienes.
  • OTA (octadecatetraenoic acid), even rarer, strengthens this effect by helping calm the inflammatory cascade.
• Rare antioxidants: furan fatty acids and carotenoids that tackle oxidative stress with potency comparable to vitamin C.
• Broad joint benefits: its lipids also curb osteoclast activity (cells that "break down" bone beneath cartilage), helping maintain stronger joint stability.
• Robust clinical evidence: multiple studies (Pollard et al., 2006; Vijarnsorn et al., 2019) report meaningful mobility gains and good tolerability in dogs with arthritis.
• Superior bioavailability: some of the Omega-3 in green-lipped mussel is bound to phospholipids. Unlike the triglycerides found in fish oils, phospholipids can be readily incorporated into cell membranes, helping EPA, DHA and ETA reach target tissues.

In short, green-lipped mussel stands out for its diverse Omega-3 profile, documented mobility benefits and a lipid form that supports absorption.

Conclusion

• Not all Omega-3s are equal: only EPA, DHA and select rare Omega-3s such as ETA and OTA directly target joint inflammation.
• The benefits are evidence-based: clinical studies show better mobility, less pain and, in some cases, reduced need for anti-inflammatories.
• The source makes a difference: plant oils mostly provide ALA, which dogs convert poorly; marine oils deliver EPA and DHA; green-lipped mussel oil brings together EPA, DHA, ETA and OTA, plus rare antioxidants.
• Part of a wider care plan: Omega-3s won't replace veterinary care, but they work well in a multimodal plan alongside weight management, gentle exercise and regular check-ups.
• Patience and consistency: benefits usually show after several weeks of daily supplementation (typically 6 to 12 weeks).

Adding a trusted Omega-3 source to your dog's diet is an investment in their comfort and long-term mobility. For owners looking to give their dog a reliable, effective Omega-3 source, New Zealand green-lipped mussel oil is a particularly well-documented option.

Discover PERNIXOL®, the liquid supplement from Laboratoire Sensilia, made with New Zealand green-lipped mussel oil and microalgae oil, rich in highly bioavailable Omega-3s to support joint comfort and mobility.

Scientific references

• Rahman MM, Bhattacharya A, Fernandes G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. Journal of Cellular Physiology. 2008;214(1):201-209. DOI: 10.1002/jcp.21188
• Ma J, Kitaura H, Ogawa S, et al. Docosahexaenoic acid inhibits TNF-α-induced osteoclast formation and orthodontic tooth movement through GPR120. Frontiers in Immunology. 2023;13:929690. DOI: 10.3389/fimmu.2022.929690
• Roush JK, Cross AR, Renberg WC, et al. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. Journal of the American Veterinary Medical Association. 2010;236(1):67-73. DOI: 10.2460/javma.236.1.67
• Moreau M, Troncy E, Del Castillo JR, et al. Effects of feeding a high omega-3 fatty acids diet in dogs with naturally occurring osteoarthritis. Journal of Animal Physiology and Animal Nutrition. 2013;97(5):830-837. DOI: 10.1111/j.1439-0396.2012.01325.x
• Mehler SJ, May LR, King C, et al. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2016;109:1-7. DOI: 10.1016/j.plefa.2016.03.015
• Fritsch D, Allen TA, Dodd CE, et al. Dose-titration effects of fish oil in osteoarthritic dogs. Journal of Veterinary Internal Medicine. 2010;24(5):1020-1026. DOI: 10.1111/j.1939-1676.2010.0572.x
• Hansen RA, Harris MA, Pluhar GE, et al. Fish oil decreases matrix metalloproteinases in knee synovia of dogs with inflammatory joint disease. Journal of Nutritional Biochemistry. 2008;19(2):101-108. DOI: 10.1016/j.jnutbio.2007.01.008
• Pollard B, Guilford WG, Ankenbauer-Perkins KL, Hedderley D. Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. New Zealand Veterinary Journal. 2006;54(3):114-118. DOI: 10.1080/00480169.2006.36622
• Vijarnsorn M, Kwananocha I, Kashemsant N, et al. The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis. BMC Veterinary Research. 2019;15(1):349. DOI: 10.1186/s12917-019-2110-7
• McPhee S, Hodges LD, Wright PF, et al. Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology. 2007;146(3):346-356. DOI: 10.1016/j.cbpb.2006.11.001
• Treschow AP, Hodges LD, Wright PF, et al. Novel anti-inflammatory omega-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology. 2007;147(4):645-656. DOI: 10.1016/j.cbpb.2007.04.004
• Siriarchavatana P, Kruger MC, Miller MR, et al. Non-polar lipid from greenshell mussel (Perna canaliculus) inhibits osteoclast differentiation. Bone Reports. 2021;15:101132. DOI: 10.1016/j.bonr.2021.101132
• Xie Y, Zhou W, Zhong Z, et al. Docosahexaenoic acid inhibits bone remodeling and vessel formation in the osteochondral unit in a rat model. Biomedicine & Pharmacotherapy. 2019;114:108811. DOI: 10.1016/j.biopha.2019.108811
• Feng L, Yang Z, Li Y, et al. Malat1 attenuated the rescuing effects of docosahexaenoic acid on osteoarthritis treatment via repressing its chondroprotective and chondrogenesis activities. Biomedicine & Pharmacotherapy. 2022;154:113608. DOI: 10.1016/j.biopha.2022.113608
• Wann AK, Mistry J, Blain EJ, et al. Eicosapentaenoic acid and docosahexaenoic acid reduce interleukin-1β-mediated cartilage degradation. Arthritis Research & Therapy. 2010;12(6). DOI: 10.1186/ar3183
• Wang Z, Guo A, Ma L, et al. Docosahexenoic acid treatment ameliorates cartilage degeneration via a p38 MAPK-dependent mechanism. International Journal of Molecular Medicine. 2016;37(6):1542-1550. DOI: 10.3892/ijmm.2016.2567
• Ma J, Kitaura H, Ohori F, et al. Docosahexaenoic Acid Inhibits Osteoclastogenesis via FFAR4-Mediated Regulation of Inflammatory Cytokines. Molecules. 2025;30(15):3180. DOI: 10.3390/molecules30153180
• Jiang X, Xue Y, Mustafa M, Xing Z. An updated review of the effects of eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins on bone preservation. Prostaglandins & Other Lipid Mediators. 2022;160:106630. DOI: 10.1016/j.prostaglandins.2022.106630
• Fritsch DA, Allen TA, Dodd CE, et al. A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis. Journal of the American Veterinary Medical Association. 2010;236(5):535-539. DOI: 10.2460/javma.236.5.535
• Fritsch DA, Allen TA, Jewell DE, et al. A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on serum fatty acid concentrations and owner assessment of arthritic dogs. Journal of the American Veterinary Medical Association. 2010;236(1):59-66. DOI: 10.2460/javma.236.1.59
• Corbee RJ, Barnier MM, van de Lest CHA, Hazewinkel HAW. The effect of dietary long-chain omega-3 fatty acid supplementation on owner’s perception of behaviour and locomotion in dogs with osteoarthritis. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2016;109:1-7. DOI: 10.1016/j.plefa.2016.04.003
• Fritsch M, Reese S, Kölle P, et al. Omega-3 supplementation improves pain scores and quality of life in dogs. Animals. 2024;14(3):374. DOI: 10.3390/ani14030374
• Vandeweerd JM, Coisnon C, Clegg P, et al. Systematic review of efficacy of nutraceuticals to alleviate clinical signs of osteoarthritis. International Journal of Molecular Sciences. 2022;23(9):4709. DOI: 10.3390/ijms23094709

This article was produced by the Sensilia R&D team, specialists in animal nutrition.